Symptoms, laboratory, ECG and imaging data
| Symptoms (n=70), n (%) | Count |
| Chest pain | 70 (100%) |
| Palpitations | 14 (20.0%) |
| Dyspnoea | 21 (30.0%) |
| Diaphoresis | 6 (8.6%) |
| Non-specific symptoms (dizziness, vomiting, fatigue) | 33 (47.1%) |
| Laboratory test | Value |
| Troponin (n=70), median fold increase | 138.3 (IQR 56.9–315.0) |
| Testing/imaging | Count |
| ECG (n=70), n (%) | |
| Abnormal | 49 (70.0%) |
| Normal | 21 (30.0%) |
| Abnormal ECG findings or arrhythmias (n=49) | |
| ST-wave or T-wave changes/elevation | 28 (57.1%) |
| ST segment depression in AVR | 9 (18.4%) |
| PR depression without reciprocal ST depression | 7 (14.3%) |
| AV node conduction delay | 3 (6.1%) |
| T wave inversion | 3 (6.1%) |
| Other | 9 (18.4%) |
| Echocardiogram (n=68) | |
| Normal function | 62 (91.2%) |
| Abnormal function | 8 (8.8%) |
| Systolic dysfunction | 5 (62.5%) |
| Wall motion abnormalities | 2 (25.0%) |
| LV strain | 1 (12.5%) |
| Cardiac MRI (n=36) | |
| Abnormal findings, n (%) | 33 (91.7%) |
| Late gadolinium enhancement | 32 (97.0%) |
| Myocardial oedema | 20 (60.6%) |
| Other abnormality on T2 imaging | 9 (27.3%) |
| Pericardial effusion or inflammation | 5 (15.2%) |
| Fibrosis | 2 (2.4%) |
LV, Left ventricular.